Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled, ‘Lab Automation Market Size, Share, Forecast, & Trends Analysis by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, LIMS, ELN) Application (Drug Discovery, Diagnostics, Genomics) End User – Global Forecast to 2031.’
According to this latest publication from Meticulous Research®, the global lab automation market is projected to reach $11.31 billion by 2031, at a CAGR of 7.3%. The factors driving the market are increasing pharmaceutical and biotech R&D expenditure, growing demand for automated labs and instruments, increasing prevalence of chronic and infectious diseases, and government initiatives supporting life sciences R&D. Additionally, factors such as growth in genomics and proteomics, increasing focus on food safety and quality, increasing awareness and adoption of personalized medicines, and emerging economies are a few opportunities that would help grow the market in the future.
However, the high costs of advanced lab automation equipment and funding and infrastructure limitations in developing countries are restraining the market’s growth. Additionally, equipment maintenance and repair and data security and privacy concerns are major challenges for the market’s growth.
Key Players
The key players profiled in the lab automation market report are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
The global lab automation market is segmented by Product [systems {automated liquid handling systems, automated nucleic acid purification systems, automated ELISA systems, automated microplate readers, automated storage and retrieval systems, and other lab automation systems}, and software {laboratory information management software (LIMS), electronic lab notebook (ELN), workstation/equipment automation software, and scientific data management systems (SDMS)}], Application (drug discovery, clinical diagnostics, genomics and proteomics research, and other applications), End User (pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users), and Geography. The study also evaluates industry competitors and analyzes their market share at the global and regional levels.
Based on product, in 2024, the systems segment is expected to account for the largest share of the market. Systems are automated instruments that are incorporated with advanced technologies that carry out an entire process or experiment without the need for manual intervention. Some of these instruments include automated liquid handling systems, automated ELISA systems, and automated nucleic acid purification systems, among others. Due to the automation of these instruments, the results are obtained in a short time and are accurate. Thus, the increasing prevalence of genetic diseases and the advantages of lab automation, such as high efficiency, accuracy, faster turnaround time, reduced manual intervention, and rising pharmaceutical R&D expenditure, are some of the factors supporting the largest share of this segment.
Based on application, in 2024, the drug discovery segment is expected to account for the largest share of the market. The large market share of this segment is attributed to factors such as faster and more accurate experiments, reduced manual errors, more reproducible and consistent results, increased focus on drug development, and government initiatives to support drug discovery and development. The technological advancements in the field of lab automation have led to the use of these instruments in several processes in drug discovery development to improve the precision, compliance, and replicability of results.
Based on end user, in 2024, the pharmaceutical and biotechnology companies’ segment is expected to account for the largest share of the market. The large share of the segment is attributed to the increasing pharmaceutical R&D, growing focus on increased overall productivity, expansion of pharma and biotech companies by introducing or updating labs and research centers, and rising demand for new drug discovery and development. Pharmaceutical and biotech companies have been trying to increase the throughput and sample capacity by providing lab automation instruments to laboratories or setting up new research centers. For instance, in February 2023, Automata Technologies Limited (U.K.) is a company that provides integrated laboratory automation systems. They expanded in the U.S. by providing integrated lab automation facilities to several laboratories across the country in order to accelerate scientific and health outcomes.
Geographic Review
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the lab automation market, followed by Europe. However, Asia Pacific is slated to register the largest CAGR during the forecast period. The growth of this market is primarily driven by the advancing healthcare infrastructure, expanding pharmaceutical and biotechnology industry, increasing pharmaceutical research, and supportive government initiatives.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Key questions answered in the report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Kenya IVD Market to be Worth $68.66 Billion by 2032
Read More
Cardiac Biomarkers Market to be Worth $10.08 Billion by 2031
Read More
Cytogenetics Market to be Worth $5.5 Billion by 2031
Read More
Metagenomics Market to be Worth $ 6.71 Billion by 2031
Read More
Dental Lasers Market to be Worth $618.7 million by 2032
Read More
Bakuchiol Serum Market to Reach $4.41 Million by 2032
Read More
Burn Care Market to be Worth $4.32 Billion by 2032
Read More
Africa Medical Devices Market to be Worth $7.14 Billion by 2032
Read More
Middle East Medical Devices Market to be Worth $8.8 Billion by 2032
Read More
Surgical Drills Market to be Worth $1.71 Billion by 2032
Read More
Tissue Engineering Market to reach $7.41 Billion by 2032
Read More
Dental Prosthetics Market to be Worth $ 19.6 Billion by 2032
Read More
Whole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read More
IVD Assay Development Market to be Worth $8.39 Billion by 2031
Read More
Neurogenomics Market to Reach $4.68 Billion by 2031
Read More
India VNA & PACS Market to Reach $341.6 Million by 2031
Read More
China Microarray Market to Be Worth $910.4 Million by 2031
Read More
China Neurogenomics Market to Reach $562.1 Million by 2031
Read More
ELISA Market to be Worth $32.69 Billion by 2032
Read More
DNA Sequencing Market to be Worth $21.30 Billion by 2031
Read More
Oral Care Market to be Worth $70 Billion by 2032
Read More
Spirometer Market to be Worth $1.80 Billion by 2032
Read More
Viral Vaccines Market to be Worth $64.18 Billion by 2031
Read More
Pet Care Market to be Worth $287.96 Billion by 2032
Read More
Regenerative Medicine Market to be Worth $37.27 Billion by 2031
Read More
Hemostats Market to be Worth $5.32 Billion by 2032
Read More
Bioreactors Market to be Worth $39.96 Billion by 2032
Read More
Protein Assays Market to be Worth $4.36 Billion by 2032
Read More
Veterinary API Market to Reach $15.84 Billion by 2031
Read More
Asia-Pacific NGS Automation Market to be Worth $371 Million by 2032
Read More
Latin America NGS Market to be Worth $765.2 Million by 2032
Read More
Biochemical Reagents Market to be Worth $39.61 Billion by 2032
Read More
Microarray Kits Market to be Worth $2.51 Billion by 2032
Read More
Antibody Production Market to Reach $58.35 Billion by 2032
Read More
Middle East IVD Market to be Worth $2.15 Billion by 2032
Read More
Spatial Genomics Market to be Worth $3.23 Billion by 2031
Read More
Asia-Pacific IVD Market to be Worth $36.02 Billion by 2032
Read More
Europe NGS Market to be Worth $6.40 Billion by 2032
Read More
Lab Automation Market to be Worth $11.31 Billion by 2031
Read More
Bioinformatics Market to Reach $31.71 Billion by 2031
Read More
Europe IVD Market to be Worth $39.77 Billion by 2032
Read More
Sequencing Kits Market to be Worth $25.29 Billion by 2031
Read More
Veterinary API Market to Reach $15.84 Billion by 2032
Read More
U.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read More
Sample Preparation Market to be Worth $12.77 Billion by 2031
Read More
Surgical Robots Market Worth $25.47 Billion by 2032
Read More
Medical Coatings Market Worth $3.32 Billion by 2032
Read More
Digital Therapeutics Market to be Worth $56.34 Billion by 2031
Read More
Liquid Handling Systems Market Worth $6.99 Billion by 2029
Read More
Electrosurgery Market to be Worth $8.99 Billion by 2031
Read More
Radiation Dose Management Market Worth $749.1 Million by 2029
Read More
Molecular Diagnostics Market Worth $46.69 Billion by 2030
Read More
Newborn Screening Market to be Worth $2.69 Billion by 2031
Read More
Pharmacogenomics Market to be Worth $19.5 Billion by 2031
Read More
Dental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read More
Nepal IVD Market Worth $62.7 Million by 2029
Read More
Pharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read More
Indonesia IVD Market Worth $1.11 Billion by 2029
Read More
Medical Waste Management Market Worth $17.02 billion by 2030
Read More
Empty Capsules Market Worth $4.47 Billion by 2029
Read More
Clear Aligners Market to be worth $18.8 Billion by 2030
Read More
HLA Typing Market Worth $1.9 Billion by 2029
Read More
Real-world Data Market Worth $1.66 billion by 2029
Read More
Track and Trace Solutions Market Worth $27.27 billion by 2029
Read More
Surface Disinfectant Market Worth $9.52 Billion by 2029
Read More
Electronic Lab Notebook Market Worth $787.7 million by 2029
Read More
Rapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read More
Plasma Therapy Market Worth $882.5 Million by 2028
Read More
Peripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read More
Biomaterials Market to Reach 128.7 Billion USD by 2023
Read More
Vaccine Storage Equipment Market Worth $1.83 billion by 2027
Read More
Plasma Fractionation Market Worth $46.9 Billion by 2029
Read More
Home Healthcare Market to be Worth $514.5 Billion by 2030
Read More
Cardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read More
European Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read More
Competent Cells Market Worth 2,318.6 Million USD By 2023
Read More
Cancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read More
Multimodal Imaging Market Worth $1.6 Billion By 2024
Read More
Pulse Lavage Market to be Worth $661.1 Million by 2030
Read More
Medical Cooling Systems Market Worth $2.8 Billion By 2024
Read More
Tissue Diagnostics Market Worth $8.52 Billion by 2029
Read More
Endoscopy Equipment Market Worth $59.8 Billion by 2029
Read More
African Forensic DNA Testing Market Worth $136.3 Million by 2025
Read More
Clinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read More
Infection Control Market Worth $58.2 Billion by 2027
Read More
Sleep Apnea Devices Market Worth $12.9 billion by 2027
Read More
Medical 3D Printing Market To Reach $983.2 Million By 2020
Read More
Genomics Market to be Worth $70.52 Billion by 2031
Read More
Analytical Standards Market Worth $2.66 Billion By 2027
Read More
Sterilization Equipment Market to be Worth $34.2 Billion by 2035
Read More
Telehealth Market Worth $539.73 Billion by 2029
Read More
Cell Culture Market Worth $48.63 Billion by 2029
Read More
Antimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read More
Flow Cytometry Market Worth $6.4 Billion by 2027
Read More
Medical Aesthetics Market Worth $29.43 billion by 2029
Read More
Oligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read More
In Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read More
Dental Implants Market Worth $6.52 Billion by 2029
Read More
Active Implantable Devices Market Worth 24.02 Billion USD By 2022
Read More
Ventilators Market to be Worth $13.23 Billion by 2031
Read More
Dialysis Market to be Worth $36.6 Billion by 2031
Read More
Task Trainers Market to Be Worth $2.9 Billion by 2032
Read More
Plasmapheresis Market to be Worth $2.55 Billion by 2030
Read More
Diabetes Care Devices Market Worth $31.9 Billion by 2028
Read More
Clinical Genomics Market Worth 879.0 Million USD By 2023
Read More
IVD Quality Control Market to be Worth $2.28 Billion by 2031
Read More
Laboratory Informatics Market Worth $6.1 Billion by 2030
Read More
Chromatography Data Systems Market to be Worth $1.7 billion by 2030
Read More
Bone Growth Stimulators Market Worth $1.94 Billion by 2030
Read More
Digital Diabetes Market worth $12.03 billion by 2025
Read More
Trocars Market Worth $968.5 Million by 2024
Read More
Healthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read More
Europe Hospital Beds Market to be Worth $2.09 Billion by 2030
Read More
Immunoassay Market Worth $46.49 Billion by 2028
Read More
Hospital Beds Market to Reach $7.09 Billion by 2031
Read More
Urinalysis Market Worth $2.19 billion by 2027
Read More
Medical Image Management Market Worth $7.22 billion by 2030
Read More
Breast Imaging Market Worth $7.08 Billion by 2027
Read More
VNA & PACS Market to be Worth $6.50 Billion by 2031
Read More